276 related articles for article (PubMed ID: 32356670)
1. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
[TBL] [Abstract][Full Text] [Related]
2. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
[TBL] [Abstract][Full Text] [Related]
3. Barriers to completing colonoscopy after a positive fecal occult blood test.
Azulay R; Valinsky L; Hershkowitz F; Elran E; Lederman N; Kariv R; Braunstein B; Heymann A
Isr J Health Policy Res; 2021 Feb; 10(1):11. PubMed ID: 33573698
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic.
Levi Z; Abu-Frecha N; Comanesther D; Backenstein T; Cohen AD; Eizenstein S; Flugelman A; Weinstein O
J Med Screen; 2024 Jun; 31(2):85-90. PubMed ID: 37964557
[TBL] [Abstract][Full Text] [Related]
6. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
7. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
8. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
[TBL] [Abstract][Full Text] [Related]
9. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
[TBL] [Abstract][Full Text] [Related]
11. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
12. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test.
Dupont-Lucas C; Dejardin O; Dancourt V; Launay L; Launoy G; Guittet L
Dig Liver Dis; 2011 Sep; 43(9):714-20. PubMed ID: 21530429
[TBL] [Abstract][Full Text] [Related]
13. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
Trials; 2015 Jul; 16():296. PubMed ID: 26156248
[TBL] [Abstract][Full Text] [Related]
14. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
[TBL] [Abstract][Full Text] [Related]
15. Mental Illness Is Not Associated with Adherence to Colorectal Cancer Screening: Results from the California Health Interview Survey.
Siantz E; Wu B; Shiroishi M; Vora H; Idos G
Dig Dis Sci; 2017 Jan; 62(1):224-234. PubMed ID: 27822771
[TBL] [Abstract][Full Text] [Related]
16. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
Hoeck S; van de Veerdonk W; De Brabander I
Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
[TBL] [Abstract][Full Text] [Related]
17. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients.
Liss DT; Brown T; Lee JY; Altergott M; Buchanan DR; Newland A; Park JN; Rittner SS; Baker DW
Cancer Causes Control; 2016 Jul; 27(7):881-7. PubMed ID: 27228991
[TBL] [Abstract][Full Text] [Related]
19. CRC Screening Results: Patient Comprehension and Follow-up.
Azulay R; Valinsky L; Hershkowitz F; Magnezi R
Cancer Control; 2019; 26(1):1073274819825828. PubMed ID: 30704290
[TBL] [Abstract][Full Text] [Related]
20. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
